MacroGenics, Inc. (MGNX) vs Q32 Bio Inc. (QTTB)
A side-by-side comparison of MacroGenics, Inc. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGNX
MacroGenics, Inc.
$3.67HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
QTTB
Q32 Bio Inc.
$8.11HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
Total return — MGNX vs QTTB
growth of $100 · dividends reinvested · last 9yMGNX -86.5% (-20.0%/yr)QTTB -97.5% (-33.7%/yr)MGNX compounded faster over this window
Log scale — wide-divergence pair
MGNX QTTB
MGNX vs QTTB: by the numbers
- •QTTB is the larger company ($241M vs $233M market cap).
- •QTTB is profitable (62.87% net margin) while MGNX runs a net loss (-8.70%).
- •QTTB grew revenue faster over the past five years (10.22% vs 7.33% CAGR).
Metrics side by side
Valuation
| Metric | MGNX | QTTB |
|---|---|---|
| P/E ratio | N/A | 2.91 |
| P/S ratio | 1.39 | 4.49 |
| P/B ratio | 5.44 | 2.28 |
| EV / EBITDA | N/A | 6.40 |
Profitability
| Metric | MGNX | QTTB |
|---|---|---|
| Gross margin | 71.12% | 99.84% |
| Operating margin | -48.72% | 31.45% |
| Net margin | -8.70% | 62.87% |
| ROE | -34.04% | 31.90% |
| ROIC | -16.87% | 19.43% |
Growth (annualized)
| Metric | MGNX | QTTB |
|---|---|---|
| Revenue CAGR (5Y) | 7.33% | 10.22% |
| Total return CAGR (5Y) | -28.42% | -41.51% |
Frequently asked
- Which has grown faster, MGNX or QTTB?
- Over the past five years, QTTB grew revenue faster — MGNX at a 7.33% CAGR versus QTTB at 10.22%.
- Is MGNX or QTTB more profitable?
- QTTB runs the higher net margin — MGNX at -8.70% versus QTTB at 62.87%.
- How have MGNX and QTTB total returns compared?
- Over the past 5 years, MGNX delivered -28.42% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Q32 Bio P/E ratioMacroGenics ROEQ32 Bio ROEMacroGenics operating marginQ32 Bio operating marginMacroGenics revenue growthQ32 Bio revenue growthMacroGenics free cash flowQ32 Bio free cash flow
MacroGenics & Q32 Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.